The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
Ryght AI tackles these hurdles with its AI Site Twin platform
Clinical trial enrollment has long been a bottleneck in drug development
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
This collaboration turns kitting into a strategic advantage for sponsors and sites
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Subscribe To Our Newsletter & Stay Updated
